EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/16/2024
Back to search
Official data from USPTO
EVITATEST THE RISK-FREE CHROMOSOME ANALYSIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
02/16/2024
Trademark type
Combined
Nice classes
44
Filing date
06/15/2021
Registration date
11/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2022
Last transaction
02/16/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
99
Owner location
Vejle, DK
Examiner
KHAN, AHSEN M
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "EVITATEST" in blue with the words "THE RISK-FREE CHROMOSOME ANALYSIS" in blue to the right of "EVITATEST".
Holders and representatives
Holders
A. A. (pessoa física)
Representatives
Michael R. Rizzo Saunders & Silverstein LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicesmedical diagnosis and treatment of prenatal disorders; Medical servicesmedical testing for diagnostic or treatment purposes for prenatal disorders; Medical servicescell-based non-invasive medical diagnosis of prenatal disorders; Performing non-invasive medical diagnosis of prenatal disorders; Medical services relating to the isolation of human fetal cells from maternal human bloodperforming medical testing on human fetal cells separated from maternal blood for diagnosing and treating prenatal disordersmedical diagnosis of prenatal disorders via analysis of samples of human fetal cells isolated from maternal human blood; Medical servicesperforming genetic testing on human fetal cells isolated from maternal human blood for medical purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/16/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/16/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
09/27/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/27/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/09/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/09/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/19/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/24/2022
PUBO
PUBLISHED FOR OPPOSITION
05/24/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2022
DOCK
ASSIGNED TO EXAMINER
04/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/16/2022
ALIE
ASSIGNED TO LIE
03/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2021
GNRT
NON-FINAL ACTION E-MAILED
12/15/2021
CNRT
NON-FINAL ACTION WRITTEN
12/15/2021
DOCK
ASSIGNED TO EXAMINER
12/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2021
NWAP
NEW APPLICATION ENTERED
06/18/2021
Continuous trademark protection
Get notified about every new filing that threatens EVITATEST THE RISK-FREE CHROMOSOME ANALYSIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.